Literature DB >> 12176418

CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibited.

M D Säemann1, P Kelemen, M Zeyda, G Böhmig, G Staffler, G J Zlabinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176418     DOI: 10.1016/s0041-1345(02)02907-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Janus kinase-3 dependent inflammatory responses in allergic asthma.

Authors:  Rama Malaviya; Debra L Laskin; Ravi Malaviya
Journal:  Int Immunopharmacol       Date:  2010-04-27       Impact factor: 4.932

Review 2.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

4.  Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation.

Authors:  Anna Sinistro; Chiara Ciaprini; Silvia Natoli; Emanuele Sussarello; Francesca Calò Carducci; Cristiana Almerighi; Marcella Capozzi; Francesca Bolacchi; Giovanni Rocchi; Alberto Bergamini
Journal:  Immunology       Date:  2007-06-29       Impact factor: 7.397

5.  CD40 signaling to the rescue: A CD8 exhaustion perspective in chronic infectious diseases.

Authors:  Rajarshi Bhadra; Dustin A Cobb; Imtiaz A Khan
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

6.  Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.

Authors:  Seok-Joo Lee; Hyun-Je Kim; Na-Ri Byun; Chung-Gyu Park
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.